Leukemia Clinical Trials

Showing 6521-6540 of 10,987 trials

Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC

NCT04641130

This is a single center open study designed to determine the concentration of airborne birch pollen inducing an allergic conjunctivitis response in individuals allergic to birch pollen, during allergen exposures in the Alyatec environmental exposure chamber (EEC).

Allergic Conjunctivitis

Alyatec16 participantsStarted Jul 2017

Strasbourg, Grand Est, France

COMPLETED

Realities, Expectations and Attitudes to Life Support Technologies in Intensive Care for Octogenarians:

NCT01293708

The purpose of this study is to understand the realities, expectations and attitudes of patients 80+ and their families about the use of life-sustaining technology, and to document the patient outcomes and family experiences associated with surviving and not surviving critical illness. Specifically in this project the investigators will determine the real outcomes of critical illness experienced by octogenarians.

Critically Ill

Daren K. Heyland1,504 participantsStarted Sep 2009

Calgary, Alberta, Canada • Calgary, Alberta, Canada • Calgary, Alberta, Canada +21 more locations

Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC

Realities, Expectations and Attitudes to Life Support Technologies in Intensive Care for Octogenarians:

Related Searches

Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC

Bone Marrow Transplant in Treating Patients With Hematologic Cancers

Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD

Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

An Open-label, Dose Escalation Study to Assess the Pharmacokinetics of of ASA404 in Adult Cancer Patients With Impaired Hepatic Function

Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy

Masitinib Plus Gemcitabine in Pancreatic Cancer

Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease

NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia

A Study Of Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients

Vandetanib in Advanced NSCLC With RET Rearrangement

Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation

Intra-Osseous Co-Transplant of UCB and hMSC

Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia

A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain Metastases

Health Care Utilisation Among Survivors of Childhood Acute Lymphoblastic Leukaemia